Fortress Biotech, Inc. 4
4 · Fortress Biotech, Inc. · Filed Jan 24, 2017
Insider Transaction Report
Form 4
Hoenlein Malcolm
Director
Transactions
- Award
Deferred Restricted Stock Units
2017-01-01+16,666→ 33,332 totalExercise: $0.00→ Common Stock (16,666 underlying)
Holdings
- 55,000
Common Stock, par value $0.001
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.
- [F2]Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.